Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Frankel, Amylynne, M.D..
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Stiefel, a GSK Company
Information provided by:
Frankel, Amylynne, M.D.
ClinicalTrials.gov Identifier:
NCT01228409
First received: October 21, 2010
Last updated: June 21, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)